- Home
- RRC vs BRKR Comparison
RRC vs BRKR Comparison
Compare RRC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRC | BRKR |
|---|---|---|
| Founded | 1976 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.3B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | RRC | BRKR |
|---|---|---|
| Price | $36.30 | $42.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 13 |
| Target Price | $41.29 | ★ $52.08 |
| AVG Volume (30 Days) | ★ 3.2M | 2.4M |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.01% | 0.48% |
| EPS Growth | ★ 19.84 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | $2,891,506,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $25.70 | $3.64 |
| Revenue Next Year | $10.72 | $1.52 |
| P/E Ratio | $15.07 | ★ N/A |
| Revenue Growth | ★ 24.57 | 6.10 |
| 52 Week Low | $30.32 | $28.53 |
| 52 Week High | $43.50 | $56.22 |
Technical Indicators
Market Signals| Indicator | RRC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 36.88 |
| Support Level | $35.30 | $40.85 |
| Resistance Level | $37.29 | $42.58 |
| Average True Range (ATR) | 1.14 | 1.81 |
| MACD | 0.00 | -0.56 |
| Stochastic Oscillator | 38.83 | 14.29 |
Price Performance
Historical ComparisonAbout RRC Range Resources Corporation
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.2 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.